Co-Authors
This is a "connection" page, showing publications co-authored by Stanley Xu and Bing Han.
Connection Strength
1.392
-
A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine. Am J Epidemiol. 2025 Jun 04.
Score: 0.246
-
Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines. Vaccine. 2025 Apr 19; 53:127074.
Score: 0.244
-
Ischemic Stroke After Bivalent COVID-19 Vaccination: Self-Controlled Case Series Study. JMIR Public Health Surveill. 2024 Jun 25; 10:e53807.
Score: 0.231
-
A Propensity Score Approach and a Partitioned Approach for the Self-Controlled Case Series Design to Evaluate Safety of a 2-dose Vaccine Series: Application to myocarditis/pericarditis following mRNA COVID-19 vaccination. Am J Epidemiol. 2024 Jun 21.
Score: 0.231
-
Factors associated with uptake of bivalent mRNA COVID-19 vaccines in a large US health care system. Vaccine. 2023 Nov 30; 41(49):7460-7468.
Score: 0.221
-
Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study. JMIR Public Health Surveill. 2023 Oct 04; 9:e46318.
Score: 0.219